Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ATAI Life Sciences N.V. Director's Dealing 2021

Jun 18, 2021

32049_dirs_2021-06-17_d0d1fb48-f9b5-4fd8-89ac-f25640ba7d4f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ATAI Life Sciences B.V. (ATAI)
CIK: 0001840904
Period of Report: 2021-06-17

Reporting Person: Rao Srinivas (See Remarks)

More from ATAI Life Sciences N.V.

Regulatory Filings 2026
Mar 20
Regulatory Filings 2025
Dec 30
Regulatory Filings 2025
Dec 30
Regulatory Filings 2025
Dec 30
Regulatory Filings 2025
Dec 5
Capital/Financing Update 2025
Dec 5
Director's Dealing 2025
Nov 26
Interim / Quarterly Report 2025
Nov 12
Earnings Release 2025
Nov 12
Director's Dealing 2025
Nov 7
View all filings →